Literature DB >> 10854236

Perturbation of hyaluronan interactions by soluble CD44 inhibits growth of murine mammary carcinoma cells in ascites.

R M Peterson1, Q Yu, I Stamenkovic, B P Toole.   

Abstract

Hyaluronan accumulates in ascites during intraperitoneal proliferation of TA3/St murine mammary carcinoma cells and at sites of their invasion of the peritoneal wall. To determine whether hyaluronan is functionally involved in these events, ascites tumor formation was compared in mice injected intraperitoneally with stable transfectants of TA3/St cells that overexpress soluble CD44, a hyaluronan-binding protein, versus in mice injected with transfectants expressing mutated soluble CD44 that does not bind hyaluronan. The soluble CD44 transfectants temporarily grew at a reduced rate within the peritoneal cavity, then went into G(1) arrest and were subsequently cleared from the peritoneum. However, transfectants overexpressing mutant soluble CD44 that does not bind hyaluronan exhibited similar ascites accumulation, growth rates, and cell-cycle profiles in vivo to wild-type and vector-transfected TA3/St cells, all of which continued to grow until the tumors became fatal. The soluble CD44-transfected TA3/St cells also failed to attach to and form tumors in the peritoneal wall. When grown in vitro in soft agar, the soluble CD44 transfectants exhibited a dramatic reduction in colony formation compared to wild-type, vector-transfected, and mutant soluble CD44-transfected TA3/St cells. Thus, perturbation of hyaluronan interactions by soluble CD44 has a direct effect on the growth characteristics of these tumor cells, leading to inhibition of anchorage-independent growth in vitro and ascites growth in vivo.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10854236      PMCID: PMC1850079          DOI: 10.1016/S0002-9440(10)65086-9

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  39 in total

1.  High levels of stromal hyaluronan predict poor disease outcome in epithelial ovarian cancer.

Authors:  M A Anttila; R H Tammi; M I Tammi; K J Syrjänen; S V Saarikoski; V M Kosma
Journal:  Cancer Res       Date:  2000-01-01       Impact factor: 12.701

2.  Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium.

Authors:  V H Freedman; S I Shin
Journal:  Cell       Date:  1974-12       Impact factor: 41.582

3.  Hyaluronate and invasiveness of the rabbit V2 carcinoma.

Authors:  B P Toole; C Biswas; J Gross
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

4.  Effects of transforming growth factor beta on the anchorage-independent growth of murine epithelial JB6 cells.

Authors:  P J Wilder; A Rizzino
Journal:  Cancer Res       Date:  1991-11-01       Impact factor: 12.701

5.  Human fibrinogen specifically binds hyaluronic acid.

Authors:  R D LeBoeuf; R H Raja; G M Fuller; P H Weigel
Journal:  J Biol Chem       Date:  1986-09-25       Impact factor: 5.157

6.  Increased synthesis of hyaluronic acid by mouse mammary carcinoma cell variants with high metastatic potential.

Authors:  K Kimata; Y Honma; M Okayama; K Oguri; M Hozumi; S Suzuki
Journal:  Cancer Res       Date:  1983-03       Impact factor: 12.701

7.  Interactions between human tumor cells and fibroblasts stimulate hyaluronate synthesis.

Authors:  W Knudson; C Biswas; B P Toole
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

8.  CD44 is involved in tumor angiogenesis; an activation antigen on human endothelial cells.

Authors:  A W Griffioen; M J Coenen; C A Damen; S M Hellwig; D H van Weering; W Vooys; G H Blijham; G Groenewegen
Journal:  Blood       Date:  1997-08-01       Impact factor: 22.113

Review 9.  The role and regulation of tumour-associated hyaluronan.

Authors:  W Knudson; C Biswas; X Q Li; R E Nemec; B P Toole
Journal:  Ciba Found Symp       Date:  1989

10.  Hyaluronan-binding protein in endothelial cell morphogenesis.

Authors:  S D Banerjee; B P Toole
Journal:  J Cell Biol       Date:  1992-11       Impact factor: 10.539

View more
  27 in total

Review 1.  Hyaluronan is not just a goo!

Authors:  B P Toole
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

2.  Targeted delivery of doxorubicin by HPMA copolymer-hyaluronan bioconjugates.

Authors:  Yi Luo; Nicole J Bernshaw; Zheng-Rong Lu; Jindrich Kopecek; Glenn D Prestwich
Journal:  Pharm Res       Date:  2002-04       Impact factor: 4.200

3.  Inhibition of Functional Hyaluronan-CD44 Interactions in CD133-positive Primary Human Ovarian Carcinoma Cells by Small Hyaluronan Oligosaccharides.

Authors:  Mark G Slomiany; Lu Dai; Lauren B Tolliver; G Daniel Grass; Yiping Zeng; Bryan P Toole
Journal:  Clin Cancer Res       Date:  2009-12-15       Impact factor: 12.531

4.  Antisense inhibition of hyaluronan synthase-2 in human osteosarcoma cells inhibits hyaluronan retention and tumorigenicity.

Authors:  Yoshihiro Nishida; Warren Knudson; Cheryl B Knudson; Naoki Ishiguro
Journal:  Exp Cell Res       Date:  2005-04-21       Impact factor: 3.905

5.  In vivo evidence for the role of CD44s in promoting breast cancer metastasis to the liver.

Authors:  Allal Ouhtit; Zakaria Y Abd Elmageed; Mohamed E Abdraboh; Tong F Lioe; Madhwa H G Raj
Journal:  Am J Pathol       Date:  2007-11-08       Impact factor: 4.307

Review 6.  CD44 in cancer progression: adhesion, migration and growth regulation.

Authors:  R Marhaba; M Zöller
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

7.  Protumorigenic role of HAPLN1 and its IgV domain in malignant pleural mesothelioma.

Authors:  Alla V Ivanova; Chandra M V Goparaju; Sergey V Ivanov; Daisuke Nonaka; Christina Cruz; Amanda Beck; Fulvio Lonardo; Anil Wali; Harvey I Pass
Journal:  Clin Cancer Res       Date:  2009-04-07       Impact factor: 12.531

8.  Establishment of an in vitro assay to measure the invasion of ovarian carcinoma cells through mesothelial cell monolayers.

Authors:  Rachael C Casey; Kimberly A Koch; Theodore R Oegema; Keith M Skubitz; Stefan E Pambuccian; Suzanne M Grindle; Amy P N Skubitz
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

Review 9.  Hyaluronan: a constitutive regulator of chemoresistance and malignancy in cancer cells.

Authors:  Bryan P Toole; Mark G Slomiany
Journal:  Semin Cancer Biol       Date:  2008-03-26       Impact factor: 15.707

Review 10.  Interstitial cell migration: integrin-dependent and alternative adhesion mechanisms.

Authors:  Samuel Schmidt; Peter Friedl
Journal:  Cell Tissue Res       Date:  2009-11-17       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.